Together with our findings on serum TNFR1 levels in control subjects and HCC patients, ROC analysis revealed that EV‐NID1 and serum TNFR1 levels in combination may be a useful biomarker for HCC. This evidence concerns the gene TNFRSF1A and hepatocellular carcinoma.